Infant Formula Class Action

Jurney De La Grana Files Federal Class Action Against Abbott Laboratories

On February 17, 2022, the U.S. Food and Drug Administration (“FDA”) announced it was investigating consumer complaints of Cronobacter and Salmonella infections related to ingestion of certain Similac, Alimentum and EleCare infant formula. Our firm filed a first of its type federal class action intended to hold Abbott Laboratories accountable for illness caused by their failures.

For many infants, formula is the sole source of nutrition. Parents who entrust the nutritional wellbeing of their babies to formula manufacturers should not have to worry about infant formula being contaminated with dangerous pathogens. Unfortunately, this most recent incident involving tainted infant formula has impacted many babies. This is unacceptable. 


Call Now at (305) 600-3555 for a FREE Consultation

Class Action Details

​The FDA is advising consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:

  • the first two digits of the code are 22 through 37; and 
  • the code on the container contains K8, SH or Z2; and 
  • the expiration date is 4-1-2022 (APR 2022) or later.

Symptoms to look for:

  • Poor feeding
  • Irritability
  • Fever or temperature changes
  • Jaundice
  • Grunting breaths
  • Abnormal body movement
  • Diarrhea 
  • Abdominal cramps
  • Aches
  • Headache
  • Lethargy
  • Rash
  • Blood in the urine or stool
  • Dehydration

​If your baby became ill after consuming Similac, EleCare, or Alimentum infant formula, contact us for a free case evaluation, you may be entitled to compensation. 

Resources and Press Regarding Class Action Suit Against Abbott Laboratories

Univision Interview

Ryan A. Jurney and Rafael De La Grana, speak about the class action lawsuit against Abbott Laboratories involving baby formula that is making infants ill.

Click Here to view the full interview.

Contact Us Today For a Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy